Dr. P. The facts you cite along with the recent FDA fast track designation are the reasons why new investors are getting on board and the stock price is, and will continue to rise. The more these new investors learn about Brilacidin and Kevetrin, the more eager they will be to continue to add to their IPIX position. Momentum is building and will soon explode when the successful C-19 trial results are announced. GO IPIX!